General Electric Co: Form 10-Q for the period ended Sep 30, 2025
Filed with the SEC on Oct 21, 2025 and accepted by EDGAR at Oct 21, 2025, 06:27 ET.
Sections
No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2025-09-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2025-07-01 to 2025-09-30 | $12.18bn | us-gaap:Revenues |
| Revenue | 9 months2025-01-01 to 2025-09-30 | $33.14bn | us-gaap:Revenues |
| Research and development | 3 months2025-07-01 to 2025-09-30 | $415.0m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2025-01-01 to 2025-09-30 | $1.13bn | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2025-07-01 to 2025-09-30 | $1.20bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2025-01-01 to 2025-09-30 | $3.09bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Income tax | 3 months2025-07-01 to 2025-09-30 | $344.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2025-01-01 to 2025-09-30 | $1.01bn | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2025-07-01 to 2025-09-30 | $2.16bn | us-gaap:NetIncomeLoss |
| Net income | 9 months2025-01-01 to 2025-09-30 | $6.16bn | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2025-07-01 to 2025-09-30 | $2.02 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2025-01-01 to 2025-09-30 | $5.75 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2025-07-01 to 2025-09-30 | $2.04 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2025-01-01 to 2025-09-30 | $5.79 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2025-07-01 to 2025-09-30 | 1,065,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2025-01-01 to 2025-09-30 | 1,071,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2025-01-01 to 2025-09-30 | $6.26bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2025-01-01 to 2025-09-30 | $842.0m | us-gaap:PaymentsToAcquireProductiveAssets |
| Share repurchases | 9 months2025-01-01 to 2025-09-30 | $5.55bn | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Current assets | At period end2025-09-30 | $40.07bn | us-gaap:AssetsCurrent |
| Total assets | At period end2025-09-30 | $128.24bn | us-gaap:Assets |
| Current liabilities | At period end2025-09-30 | $37.20bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2025-09-30 | $109.22bn | us-gaap:Liabilities |
| Current portion of debt | At period end2025-09-30 | $2.07bn | us-gaap:DebtCurrent |
| Short-term borrowings | At period end2025-09-30 | $17.0m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2025-09-30 | $18.81bn | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2025-09-30 | 1,054,813,911 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0000040545-25-000132. Last ingested by Listed: Nov 13, 2026, 16:12 ET. Listed shows no prices and gives no investment advice.